DataMeds AI, Inc. (MEDS)

NASDAQ

$4,04

$+1,07

(+33,75%)

Previous Close: ⁦$3,17⁩

Market Closed

DataMeds AI, Inc. (MEDS) Live Price Chart

Last updated: ⁦2026-10-02 02:53:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NASDAQ. The stock is currently priced at $4,04, with a market capitalisation of $11,74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,82 to $12,31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$11,74M
Open	$3,90
Day's High	$504,00
Day's Low	$0,82
Previous Close	$3,17
Volume	34,33M
Average Volume	6,68M
P/E Ratio	--
52-Week High	$12,31
52-Week Low	$0,82
Dividend Yield	--
Earnings Date	--

DataMeds AI, Inc. (MEDS) Latest Closing Stock Price

DataMeds AI, Inc. (MEDS) last closed at $3,17 as of 2026-10-02 00:00:00, unchanged from the previous close of $3,17.

During the latest regular trading session, MEDS traded between $0,82 and $504,00, with a volume of 34,33M shares. The closing price was near the lower end and near the lower end of its 52-week range.

DataMeds AI, Inc. (MEDS) 7-Day Stock Price Change

Over the past seven days, DataMeds AI, Inc. (MEDS) moved from $4,28 to $4,04, representing a decline of 5,47% ($0,23).

The stock traded between $3,01 and $5,38 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 5,60 million shares, down versus the previous seven-day period, indicating lower trading activity.

MEDS 52-Week Price Position

Position in Range: 28,0%

52W Low$0,82

52W High$12,31

MEDS is currently trading at $4,04, placing it 28,0% of the way from its 52-week low of $0,82 to its 52-week high of $12,31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is DataMeds AI, Inc. (MEDS)?

DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.

DataMeds AI, Inc. Information

Industry	WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange	NASDAQ
Company Website	https://wellgisticshealth.com

How to Buy DataMeds AI, Inc. (MEDS) Stock on MEXC

Eligible investors can buy real shares of DataMeds AI, Inc. (MEDS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MEDS and Place Your Order

Open the RealStocks trading page and search for MEDS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is DataMeds AI, Inc. (MEDS) share price today?

DataMeds AI, Inc. (MEDS) is currently trading at $ 4,04, up 27,48% ($0,87) from the previous close of $ 3,17. Intraday prices update in real time during regular trading hours.

2.Is MEDS stock going up or down today?

As of 2026-10-02 00:00:00, MEDS is trading at $ 4,04, up 27,48% ($0,87) from its previous close of $ 3,17. The stock has traded between $ 0,82 and $ 504,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is MEDS pre-market price?

As of 2026-10-02 00:00:00, MEDS is trading at $ 3,93 in pre-market trading, up 23,91% ($0,76) from the previous close of $ 3,17. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MEDS after-hours price?

As of 2026-10-02 00:00:00, MEDS is trading at $ 4,00 in after-hours trading, up 26,18% ($0,83) from the regular-session close of $ 3,17. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is MEDS stock trading now?

MEDS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MEDS sit relative to its 52-week high and low?

Over the past 52 weeks, MEDS has traded between a low of $ 0,82 and a high of $ 12,31. At $ 4,04, the stock is positioned 28,0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is DataMeds AI, Inc. in?

DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is DataMeds AI, Inc.'s market capitalisation and where is it listed?

DataMeds AI, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 11,74M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MEDS valued in terms of P/E ratio and EPS?

MEDS trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does DataMeds AI, Inc. pay a dividend?

DataMeds AI, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.